IDEXX Laboratories stock heads into the open after a modest gain
Published on 09/09/2026 at 08:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IDEXX Laboratories stock closed on the Nasdaq at USD 232.40 on September 8, 2026, posting a 0.8% gain for the session. The shares traded between an intraday low of USD 229.10 and a high of USD 233.50, with roughly 620,000 shares changing hands. In the same session the S&P 500 slipped 0.4% to 7,718.41, so IDEXX Laboratories outperformed the broader benchmark ahead of today’s open.
September 8, 2026 in numbers
IDEXX Laboratories Inc. (ISIN US45168D1046, Nasdaq: IDXX) saw a relatively tight trading range on September 8, 2026, with the USD 232.40 close sitting in the upper half of the day’s band between USD 229.10 and USD 233.50. The session’s approximate 0.8% advance compared with the prior Nasdaq close came on volume of about 620,000 shares, in line with recent averages. Over the past 52 weeks the stock has traded between USD 185.00 and USD 245.00, placing the latest close roughly USD 12.60 below the 52-week high and USD 47.40 above the 52-week low. In contrast, the S&P 500’s 0.4% decline to 7,718.41 on September 8, 2026 highlighted a softer tone in the broader market.
Today’s backdrop for IDEXX Laboratories
No new company-specific release for IDEXX Laboratories was reported early on September 9, 2026, but broader macro events shape the backdrop for today’s trading. According to Forex TradingCharts, investors are focused on upcoming CPI and PPI inflation data in the United States, which can influence rate expectations and valuations across growth-oriented healthcare and diagnostics names. Broader equity sentiment also remains fragile after recent declines in major indexes, as summarized by The Motley Fool, which noted that rising crude oil prices and geopolitical tensions pulled major U.S. benchmarks lower on September 8, 2026. This combination of inflation data focus and cautious risk appetite sets the stage for how IDEXX Laboratories stock may be assessed as trading resumes today.
